Events and Conferences

Contact Veristat Now


Request A Proposal

Contact Us

On-Demand Webinar | What's New in Draft MHPD Guidance on Reporting Adverse Reactions for Marketed Products

April 12, 2021

Certus PV, a Veristat Company experts recently lead an Xtalks webinar - View it On-Demand Now

Read More

On-Demand Webinar | How to Better Plan Your Decentralized/Virtual Clinical Trial

March 2, 2021

Veristat experts recently led an Xtalks webinar on lessons learned for planning decentralized clinical trials.

Read More

Webinar | Roadmap to Market for Cell and Gene Therapies

October 12, 2020

View the On-Demand Webinar

VIEW WEBINAR

Nothing is standard about the study design, study conduct or the regulatory process in cell and gene therapy trials. Every cell and gene therapy is different due to the specific characteristics of each product, with a complicated regulatory approval process and unique therapeutic challenges.

 

Read More

Webinar | Reducing Study Build Time from Weeks to Days

October 1, 2020

View Webinar On-Demand

VIEW ON-DEMAND

Study start-up and post-go-live protocol amendments can be lengthy, costly, and disruptive to a clinical trial. But with the right technology, data managers can accelerate timelines and overcome these challenges.

Read More

Webinar | Minimize Disruption of Your Oncology Trial

June 4, 2020

View the On-Demand Webinar 

VIEW WEBINAR

As the world begins to relax restrictions, what are the lessons learned that can catapult us into the next innovation in trial operations for good? 
Read More

Webinar | Are you Ready to Begin Planning your IND Submission?

April 13, 2020

View the On-Webinar

VIEW WEBINAR

Submitting an Investigational New Drug (IND) application to the US FDA is a significant step in the development of a new drug or biologic product. But, are you ready? 
Read More

Webinar | Achieving Balance in Clinical Trial Database Design: Considerations for Enhancing Clinical Trial Efficiency

November 14, 2019

Webinar Summary:

Designing a clinical trial database is a balancing act.  Any clinical program has multiple stakeholders who have both short-term and long-term goals to achieve.   A good database designer must understand the needs and goals of the sponsor and its various functional project team members.   The designer must consider the ease of use for the clinical trial sites who will be entering the trial data, with the needs of the downstream stakeholders in biostatistics, programming, and medical writing.  Additionally, we not only need to consider today’s priorities, we also must understand the overall strategy of the clinical program, especially as it moves forward past the current stage.  

Read More

Clinical Trials Europe 2019 | Formerly PCT Europe

October 24, 2019

Veristat will be attending Clinical Trials Europe 2019,  the conference formerly known as the Partnerships in Clinical Trial Europe conference, for the first time this year.  

Read More

AMWA 2019 | 7 Habits of Highly Successful Medical Writers

October 8, 2019

Join Veristat at AMWA 2019 Medical Writing & Communication Conference to learn about the trends and opportunities in the field of medical writing and medical communications.  

Read More

Webinar | A Patient-Centric Approach to Clinical Trial Recruitment & Retention

October 3, 2019

Webinar Summary

Patient recruitment continues to be the number one reason for study delays. It is estimated for every day a drug is not on the market, $1 million USD is lost in revenue, and more importantly, patients suffering from illnesses are left waiting for products that can help them achieve their health goals or provide a better quality of life.
Read More